Belite Bio, Inc (BLTE) stock
BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
$157.72−4.84 (-2.98%)
Close on Nov 17, 2026Market cap $6.20BP/E –Yield –
Belite Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$36.99M. The highest annual figure on record is -$4.44M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$36.99M | – |
| FY2024 | Dec 31, 2024 | -$29.23M | – |
| FY2023 | Dec 31, 2023 | -$29.84M | – |
| FY2022 | Dec 31, 2022 | -$11.46M | – |
| FY2021 | Dec 31, 2021 | -$7.47M | – |
| FY2020 | Dec 31, 2020 | -$4.44M | – |
See a number that looks wrong?